W.L. GORE & ASSOCIATES GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
|
Back to Search Results |
|
Device Problem
No Apparent Adverse Event (3189)
|
Patient Problem
Rupture (2208)
|
Event Date 09/12/2017 |
Event Type
Injury
|
Manufacturer Narrative
|
(b)(4).A review of the manufacturing records for the device(s) could not be performed as item and lot numbers are unknown.Per the gore® excluder® aaa endoprosthesis instructions for use (ifu), adverse events that may occur and/or require intervention include, but are not limited to aneurysm enlargement and rupture.Per ifu, ¿in addition to the risks and benefits of endovascular repair, the physician should assess the patient¿s commitment and compliance to post-operative follow-up as necessary to ensure continuing safe and effective results.¿ additionally, the ifu states ¿all patients should be advised this treatment modality requires long-term, regular follow-up to assess patient¿s health status and stent-graft performance.¿.
|
|
Event Description
|
On an unknown date in 2011, the patient was implanted with a gore® excluder® aaa endoprosthesis (item and lot number unknown) to treat an abdominal aortic aneurysm.According to the report, the patient was subsequently lost to follow-up.On (b)(6) 2017, the patient presented emergently to the facility with abdominal pain.An examination revealed a ruptured left common iliac artery.According to the report, aortoiliac disease progression led to vessel dilation and rupture.The patient was implanted with two non-gore manufactured endografts to treat the rupture.The rupture was resolved and the patient tolerated the procedure.
|
|
Search Alerts/Recalls
|
|
|